# 8-K filed: LIXTE BIOTECHNOLOGY HOLDINGS, INC.

> sec 8k · VERIFIED · 2026-07-02

Filed: 2026-07-02 AccNo: 0001493152-26-031870 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.02: Unregistered Sales of Equity Securities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

- Company: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- Sector: biotech
- Primary source: https://www.sec.gov/Archives/edgar/data/1335105/000149315226031870/0001493152-26-031870-index.htm

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.